Obesity, Gut-Brain Axis, and Type 1 Diabetes: Unexplored Peptide Territory

Review explores the gut-brain axis in type 1 diabetes and obesity, examining how gut peptides including GLP-1 and GIP may influence T1D pathophysiology.

Argyrakopoulou, Georgia et al.·Current obesity reports·2025·Preliminary EvidenceReview
RPEP-09973ReviewPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Preliminary Evidence
Sample
N=N/A
Participants
People with type 1 diabetes and obesity

What This Study Found

Review explores the gut-brain axis in type 1 diabetes and obesity, examining how gut peptides including GLP-1 and GIP may influence T1D pathophysiology.

Key Numbers

No specific numerical data — review of mechanisms and emerging evidence.

How They Did This

In publication.

Why This Research Matters

Relevant to peptide therapeutics.

The Bigger Picture

Advances peptide evidence.

What This Study Doesn't Tell Us

In publication.

Questions This Raises

  • ?Long-term implications?
  • ?Evidence comparison?
  • ?Next steps?

Trust & Context

Key Stat:
Key finding Review explores the gut-brain axis in type 1 diabetes and obesity, examining how gut peptides includ
Evidence Grade:
Based on design.
Study Age:
Published in 2025.
Original Title:
Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: Terra Incognita?
Published In:
Current obesity reports, 14(1), 61 (2025)
Database ID:
RPEP-09973

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What does this mean?

Review explores the gut-brain axis in type 1 diabetes and obesity, examining how gut peptides including GLP-1 and GIP may influence T1D pathophysiology.

How reliable?

Consult publication.

Read More on RethinkPeptides

Cite This Study

RPEP-09973·https://rethinkpeptides.com/research/RPEP-09973

APA

Argyrakopoulou, Georgia; Gitsi, Evdoxia; Dalamaga, Maria; Kokkinos, Alexander. (2025). Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: Terra Incognita?. Current obesity reports, 14(1), 61. https://doi.org/10.1007/s13679-025-00654-8

MLA

Argyrakopoulou, Georgia, et al. "Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: Terra Incognita?." Current obesity reports, 2025. https://doi.org/10.1007/s13679-025-00654-8

RethinkPeptides

RethinkPeptides Research Database. "Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: ..." RPEP-09973. Retrieved from https://rethinkpeptides.com/research/argyrakopoulou-2025-obesity-and-the-gutbrain

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.